Evaluación ecocardiográfica de la efectividad del sildenafil en insuficiencia cardíaca e hipertensión pulmonar
Open Access
- 29 June 2023
- journal article
- Published by Federacion Argentina de Cardiología in Revista de la Federación Argentina de Cardiología
- Vol. 52 (2) , 77-84
Abstract
Introduction: Echocardiography is a key diagnostic tool for detecting pulmonary hypertension in heart failure. Sildenafil is indicated in this context; however, its impact is still uncertain. Objectives: To evaluate the effectiveness of sildenafil in patients with reduced left ventricular ejection fraction (LVEF), heart failure and pulmonary hypertension by echocardiography. Methods: A therapeutic evaluation study was performed in 27 patients with symptoms ofheart failure and LVEF≤40%, who had echocardiographic signs of pulmonary hypertension. Out of the 27 patients, 20 had adherence to the drug and 7 did not; these two groups were analyzed by clinical, laboratory and echocardiographic variables. The echocardiographic variables of pulmonaryhemodynamics were evaluated at the time of indicating sildenafil and twelve weeks later. Follow-up was performed to look for the occurrence of cardiovascular adverse events. A multivariate analysis and a Kaplan-Meier survival curve were performed. The statistical significance level was p<0.05. Results: an improvement in pulmonary pressures was evident in echocardiogram after the use of sildenafil in the group of patients who adhered to the drug compared to those who did not, systolic pressure 41.25±13.94 vs 61.57±12.08 mmHg, p=0.002; mean pressure 29.42±7.36 vs 40.00±4.04 mmHg, p=0.001; diastolic pressure 16.90±5.04 vs 28.43±6.32 mmHg, p=0.0001. Adverse event-free survival was higher in the group that adhered to the drug HR=0.002; p=0.002. Conclusions: Sildenafil was effective in improving the hemodynamic profile, and those who adhered toit had better survival.Keywords
This publication has 22 references indexed in Scilit:
- The dysfunctional right ventricle: the importance of multi-modality imagingEuropean Heart Journal - Cardiovascular Imaging, 2022
- Acute Unloading Effects of Sildenafil Enhance Right Ventricular–Pulmonary Artery Coupling in Heart FailureJournal of Cardiac Failure, 2021
- Pressure–volume loop validation of TAPSE/PASP for right ventricular arterial coupling in heart failure with pulmonary hypertensionEuropean Heart Journal - Cardiovascular Imaging, 2020
- Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantationAdvances in Medical Sciences, 2020
- Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LVCurrent Heart Failure Reports, 2019
- Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysisInternational Journal of Cardiology, 2018
- Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertensionInternational Journal of Cardiology, 2018
- Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in miceScientific Reports, 2018
- Left ventricular heart failure and pulmonary hypertensionEuropean Heart Journal, 2015